High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.

Terkeltaub, Robert A; Furst, Daniel E; Bennett, Katherine; Kook, Karin A; Crockett, R S; Davis, Matthew W

Terkeltaub, Robert A; Furst, Daniel E; Bennett, Katherine; Kook, Karin A; Crockett, R S; Davis, Matthew W.

Affiliation

Terkeltaub RA; VAMC San Diego, and University of California, San Diego, CA 92161, USA. rterkeltaub@ucsd.edu

Arthritis Rheum ; 62(4): 1060-8, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20131255

Subject(s)

Colchicine/toxicity; Gout/chemically induced; Adult; Aged; Arthralgia/chemically induced; Colchicine/administration & dosage; Colchicine/adverse effects; Colchicine/pharmacokinetics; Diarrhea/chemically induced; Dose-Response Relationship, Drug; Female; Humans; Male; Melena/chemically induced; Middle Aged; Nausea/chemically induced; Pain/chemically induced; Placebos; Racial Groups; Reference Values; Vomiting/chemically induced

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colchicine / Gout Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Arthritis Rheum Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google